Ildong Pharmaceutical company had a signing ceremony with AstraZeneca Korea for the co-promotion of the type 2 diabetes treatment
On Mar 4, Ildong Pharmaceutical company had a signing ceremony with AstraZeneca Korea for the co-promotion of the type 2 diabetes treatment Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin and metformin complexe with extended release).
Starting from March, both companies will carry out sal...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
